logo
Plus   Neg
Share
Email

East West Bancorp Q1 Profit Rises; Lifts FY12 EPS View - Quick Facts

East West Bancorp Inc. (EWBC) reported first-quarter net income available to common stockholders of $66.37 million or $0.45 per share, up from $54.36 million or $0.37 per share in the same quarter of last year. Analysts polled by Thomson Reuters expected the company to report earnings of $0.43 per share for the quarter. Analysts' estimates typically exclude special items.

Earnings per share for the first quarter of 2012 was 22% higher than the prior year. This increase in earnings is reflective of healthy, profitable and prudent growth in our loan and deposit portfolios, which has resulted in a strong net interest margin of 4.21% and a reduced cost of deposits down to 0.47%.

Net interest income for the quarter rose to $218.92 million from $208.83 million in the prior year quarter. Non-interest income was $21.74 million, up from $11.04 million in year ago quarter.

The company expects earnings per share for the second quarter of 2012 to be in the range of $0.43 to $0.45 per share. Analysts expect the company to report earnings of $0.45 per share for the second-quarter.

The company currently estimates that earnings per share for the full year of 2012 will range from $1.78 to $1.82, or an increase of 11% to 14% from 2011. Also, this updated guidance for the full year 2012 is an increase of $0.04 per share from its previous guidance. Analysts expect the company to report earnings of $1.83 per share for fiscal 2012.

by RTTNews Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
An administrative law judge has ruled that Minnesota regulators should approve Enbridge Inc.'s proposal to replace its aging Line 3 crude oil pipeline only if the company follows the existing route and not its preferred route. Enbridge has applied to replace its Line 3 pipeline from Alberta with new pipe along its existing route. In Minnesota, the planned route deviates from the existing route. CLICK HERE to see America's 10 Best-Selling Drugs Despite high drug costs, most of the top-selling drugs saw sales gains in 2017 compared to the prior year. A large number of the best-selling drugs are primarily for the treatment and management of cancer, diabetes, inflammatory disorders, and HIV... Most Americans have access to health care, though costs and services vary from state to state. However, higher costs do not necessarily translate into better results. The U.S. continues to be outperformed by other wealthy nations on several measures like life expectancy, disease burden and health...
Follow RTT